Etoposide EP Impurity E
| Catalog No. | KME122006 |
|---|---|
| CAS No. | 6559-91-7 |
| Alt. name | Teniposide USP Related Compound A ; 4′-desmethylepipodophyllotoxin (EP) |
| Formula | C21H20O8 |
| FW | 400.4 |
| Unit | Price | Stock |
|---|---|---|
| 100 mg | Enquire | Enquire |
| Chemical Name: | (5R,5aR,8aR,9S)-9-Hydroxy-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydro[2]benzofuro[5,6-f][1,3]benzodioxol-6(5aH)-one (as per EP) |
|---|---|
| Purity: | >95% |
| Storage: | Store at 2-8 deg. C for long term storage |
| Shipping: | Product is stable to be Shipped at Room Temperature |
Etoposide EP Impurity E is chemically (5R,5aR,8aR,9S)-9-Hydroxy-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydro[2]benzofuro[5,6-f][1,3]benzodioxol-6(5aH)-one (as per EP) .
Etoposide EP Impurity E is supplied with detailed characterization data compliant with regulatory guideline.
Etoposide EP Impurity E can be used for the analytical method development, method validation (AMV), Quality Controlled (QC)
application for Abbreviated New Drug Application (ANDA) or during commercial production of Etoposide EP Impurity E.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. K.M.Pharma products are for analytical purpose only and not for human use.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. K.M.Pharma products are for analytical purpose only and not for human use.
Related Products
CAT No: KME122001
CAT No: KME122002
CAT No: KME122003
CAT No: KME122005
CAT No: KME122014
CAT No: KME122007
CAT No: KME122008
CAT No: KME122009
CAT No: KME122010
CAT No: KME122011
CAT No: KME122012
CAT No: KME122013
CAT No: KME122016
CAT No: KME122017
CAT No: KME122018
CAT No: KME122019
CAT No: KME122020
CAT No: KME122021
CAT No: KME122004
CAT No: KME122015
CAT No: KME122022
